Show simple item record

dc.contributor.authorPlachouras, Diamantis
dc.contributor.authorLötsch, Felix
dc.contributor.authorKohlenberg, Anke
dc.contributor.authorMonnet, Dominique L
dc.date.accessioned2021-05-02T19:27:28Z
dc.date.available2021-05-02T19:27:28Z
dc.identifier.pmid32234118
dc.identifier.doi10.2807/1560-7917.ES.2020.25.12.2000240
dc.identifier.urihttp://hdl.handle.net/10029/624919
dc.description.abstractBetween January 2018 and May 2019, 349 cases of Candida auris were reported in the European Union/European Economic Area*, 257 (73.6%) colonisations, 84 (24.1%) bloodstream infections, seven (2.0%) other infections and one case of unknown infection/colonisation status (0.3%). Most cases (97.1%, n = 339) were reported from Spain or the United Kingdom, but also for the first time in Greece, the Netherlands and Poland. Laboratory capacity and preparedness has improved since January 2018.en_US
dc.language.isoenen_US
dc.subjectCandida aurisen_US
dc.subjectepidemiologyen_US
dc.subjectlaboratory capacityen_US
dc.subjectpreparednessen_US
dc.titleCandida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019.en_US
dc.typeArticleen_US
dc.identifier.eissn1560-7917
dc.identifier.journalEuro Surveill 2020; 25(12):pii.2000240en_US
dc.source.journaltitleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
dc.source.volume25
dc.source.issue12
dc.source.countrySweden


This item appears in the following Collection(s)

Show simple item record